BIOMAT Database Logo BIOMAT Database Logo

Perioperative Alanyl-Glutamine-Supplemented Parenteral Nutrition in Chronic Radiation Enteritis Patients With Surgical Intestinal Obstruction: A Prospective, Randomized, Controlled Study. 2016

Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, P. R. China.

BACKGROUND A prospective, randomized, controlled study was performed to evaluate the effects of perioperative alanyl-glutamine-supplemented parenteral nutrition (PN) support on the immunologic function, intestinal permeability, and nutrition status of surgical patients with chronic radiation enteritis (CRE)-induced intestinal obstruction. METHODS Patients who received 0.4 g/kg/d alanyl-glutamine and isonitrogenous PN were assigned to an alanyl-glutamine-supplemented PN (Gln-PN) group and a control group, respectively. Serum levels of alanine aminotransferase and glutamine, body fat mass (FM), immunologic function, and intestinal permeability were measured before and after surgery. RESULTS Serum glutamine levels of the Gln-PN group significantly exceeded that of the control group (P < .001; Gln-PN, baseline 460.7 ± 42.5 vs 523.3 ± 48.6 µmol/L on postoperative day 14 [POD14], P < .001; control, baseline 451.9 ± 44.0 vs 453.8 ± 42.3 µmol/L on POD14, P = .708). Lactulose/mannitol ratios of both groups decreased over time (Gln-PN, baseline 0.129 ± 0.0403 vs 0.024 ± 0.0107 on POD1 4; control, baseline 0.125 ± 0.0378 vs 0.044 ± 0.0126 on POD14, P < .001 in both groups). CD4/CD8-positive T-lymphocyte ratios significantly rose in both groups, with significant intergroup difference (P < .001; Gln-PN, baseline 1.36 ± 0.32 vs 1.82 ± 0.30 on POD14, P < .001; control, baseline 1.37 ± 0.25 vs 1.63 ± 0.31 on POD14, P < .001). In the Gln-PN group, FM increased from 3.68 ± 1.68 kg at baseline to 5.22 ± 1.42 kg on POD14 (P < .001). FM of control group increased from 3.84 ± 1.57 kg at baseline to 5.40 ± 1.54 kg on POD14 (P < .001). However, there were no significant intergroup differences (P = .614). CONCLUSIONS Gln-PN significantly boosted the immune state and decreased the intestinal permeability of CRE patients. However, Gln-PN was not superior to standard PN in improving the nutrition state and intestinal motility of surgical patients with CRE-induced intestinal obstruction.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007415 Intestinal Obstruction Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL. Intestinal Obstructions,Obstruction, Intestinal
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D007792 Lactulose A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887) Amivalex,Duphalac,Normase
D008297 Male Males
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009752 Nutritional Status State of the body in relation to the consumption and utilization of nutrients. Nutrition Status,Status, Nutrition,Status, Nutritional
D010288 Parenteral Nutrition The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously). Intravenous Feeding,Nutrition, Parenteral,Parenteral Feeding,Feeding, Intravenous,Feeding, Parenteral,Feedings, Intravenous,Feedings, Parenteral,Intravenous Feedings,Parenteral Feedings
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods

Related Publications

Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
Alanyl-glutamine-supplemented parenteral nutrition prevents intestinal ischemia-reperfusion injury in rats.
January 2003, JPEN. Journal of parenteral and enteral nutrition,
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
Cost containment through L-alanyl-L-glutamine supplemented total parenteral nutrition after major abdominal surgery: a prospective randomized double-blind controlled study.
December 2000, Clinical nutrition (Edinburgh, Scotland),
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
Effects of parenteral nutrition supplemented with alanyl-glutamine on nutrition status in rats.
January 2005, JPEN. Journal of parenteral and enteral nutrition,
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
Alanyl-glutamine dipeptide-supplemented parenteral nutrition improves intestinal metabolism and prevents increased permeability in rats.
March 1996, Annals of surgery,
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial.
April 2016, Annals of surgery,
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis.
February 2004, Clinical nutrition (Edinburgh, Scotland),
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
L-alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis.
January 2008, JPEN. Journal of parenteral and enteral nutrition,
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
[Parenteral and enteral nutrition in surgical patients with intestinal obstruction].
May 2001, Nihon rinsho. Japanese journal of clinical medicine,
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
[The prospective study on application of parenteral nutrition with alanyl-glutamine dipeptide in chemotherapy of gastrointestinal neoplasms patients].
August 2006, Ai zheng = Aizheng = Chinese journal of cancer,
Danhua Yao, and Lei Zheng, and Jian Wang, and Mingxiao Guo, and Jianyi Yin, and Yousheng Li
L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study.
March 2006, Critical care medicine,
Copied contents to your clipboard!